Marijuana Industry Expert Alan Brochstein On GW Pharma's Earnings Tells Benzinga :NDA filing for Epidiolex Seems To Have Been Pushed Back Slightly, Co. Now Saying "Mid 2017" Instead Of H1, "Mid" Could Mean A Bit Later Than June 30th